Q1 2019 Neurocrine Biosciences Inc Earnings Call Transcript
Hello, and thank you for joining the Neurocrine Biosciences Reports First Quarter 2019 Results. (Operator Instructions) Please note, this call may be recorded.
It is now my pleasure to turn the call over to Kevin Gorman, CEO. Please go ahead.
Thank you very much, and thank you, everyone, for joining us this afternoon. Here, I'm joined with -- by Matt Abernethy, our CFO; Eiry Roberts, our CMO; Eric Benevich, our Chief Commercial Officer; and also, Kyle Gano, our Chief Business Development Officer.
Before I get started, Jane, will you please read our safe harbor statement?
Yes, good afternoon. Certain statements made in the course of this conference call that are not historical statements may be forward-looking statements, which are subject to risks and uncertainties. Information concerning factors that could cause actual results to differ materially from those contained in or
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |